Global Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Type (Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin), By Regional Outlook and Forecast, 2022 - 2028

The Global Blood Plasma Derivatives Market size is expected to reach $72.5 billion by 2028, rising at a market growth of 9.3% CAGR during the forecast period.

Blood plasma derivatives are specific protein concentrates extracted from plasma using a fractionation technique. Blood plasma derivatives include albumin, factor VIII, immunoglobulin, hyperimmune globulin, factor IX, and fresh frozen. They are commonly used to destroy viruses that trigger bleeding disorders, hepatitis B, hepatitis C, hemophilia A, immunodeficiency, hypogammaglobulinemia, hemophilia B, and human immunodeficiency virus because they are abundant in proteins, salts, minerals, hormones, vitamins, and protease inhibitors.

In addition, blood plasma derivatives aid in boosting nutrition, regulating body temperature and blood coagulation, maintaining osmotic pressure, improving respiration as well as excretion, and balancing acid-base levels. Blood Plasma Derivatives serve a crucial part in maintaining the body's normal pH balance and transferring nutrients. After fractionating blood plasma, these compounds are commonly utilized to treat a range of disorders. In hospitals, clinics, diagnostic facilities, and blood transfusion centers, blood plasma derivatives are widely preserved.

Plasma derivatives are generated by chromatographic as well as several other fractionation processes from human plasma. Additionally, certain proteins may be isolated from serum. Several plasma proteins (or their mutated variants) are also created utilizing recombinant DNA methods, in which the protein is synthesized by introducing a gene into an expression system.

Essentially, human blood derivatives are the most suitable growth supplement for hMSC development in vitro since they will avoid any infection and immunogenicity of animal origin and aid to create genetically and epigenetically healthy cells and tissue. The autologous serum is a replacement for FBS. It has been observed that autologous serum/plasma preserves the proliferative and differentiation potential of mesenchymal and bone marrow-derived stem cells and enhances cellular and genetic therapy.

COVID-19 Impact Analysis

The COVID-19 pandemic majorly impacted a number of industries all over the world. Various businesses, irrespective of their size, were majorly demolished as a result of the abrupt emergence of the pandemic. Moreover, governments throughout a number of countries were compelled to impose lockdowns within their countries in order to regulate the spread of the coronavirus, which led various economies to a steep downfall. The blood plasma derivative market was also impacted by the outbreak in the initial period as a number of research labs as well as academic institutions were turned into COVID research centers or vaccine manufacturing facilities. Due to this, a number of processes related to the development and application of blood plasma derivatives were hauled.

Market Growth Factors

A Rise in The Prevalence of Hemophilia Throughout the World

Hemophilia is a hereditary bleeding condition in which the blood fails to effectively clot due to a deficiency or reduction in a clotting factor protein. Hemophilia A, which is caused by a lack of clotting factor VIII, and hemophilia B, which is caused by a lack of clotting factor IX, are the most frequent kinds of hemophilia. Either kind can result in uncontrolled bleeding into organs, muscles, and joints, as well as chronic bleeding after traumas or surgery.

Rapidly Increasing Geriatric Population Throughout the World

In every country throughout the world, the number of aging people is increasing at an alarming rate. According to the United Nations Organization, in 2020 there will be around 727 million individuals globally aged 65 or older. By 2050, its population is projected to more than triple to about 1.5 billion. The proportion of aged individuals in the global population is anticipated to rise from 9.3% in 2020 to 16.0% by 2050. By the middle of the 21st century, one in six individuals across the world will be 65 or older. The phenomenon of population aging refers to the increased incidence and proportion of aged people in the global population.

Marketing Restraining Factor:

Availability of A Number of Affordable Alternatives to Blood Plasma

Since their emergence in the 1940s, proteins produced from human plasma have become vitally essential medicinal products. The technologies of molecular biology have given alternatives to the delivery of natural goods over the past two decades. Recombinant variants of Factor IX and Factor VIII are commercially accessible, and more plasma proteins are undergoing recombinant development. Additionally, genetic engineering gives the possibility to tweak a natural protein to increase its in vitro production efficiency or alter its therapeutic profile. More efficient production techniques, like transgenic animals or plants, may result in less expensive treatments as well as a greater supply of currently scarce items.

Application Outlook

Based on Application, the Blood Plasma Derivatives Market is segregated into Hemophilia Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, and Other Application. In 2021, the others segment recorded a substantial revenue share of the blood plasma derivatives market. The growth of the segment is rising at a very rapid pace due to the rise in infectious illness incidence as well as the demand for plasma-derived products. There is a very big number of diseases that can affect people all over the world, however, can be treated by deploying blood plasma derivatives-based therapy and drugs.

End-use Outlook

By End-User, the Blood Plasma Derivatives Market is categorized into Hospitals, Clinics, and Other End Users. In 2021, the clinics segment registered a significant revenue share of the blood plasma derivatives market. There is a surge in the growth of the segment attributed to the number of clinics that are offering more advanced and enhanced patient experiences to their patients.

Type Outlook

On the basis of Type, the Blood Plasma Derivatives Market is segmented into Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others. In 2021, the immunoglobulin segment acquired the largest revenue share of the blood plasma derivatives market. Antibodies, also known as immunoglobulins, are large, Y-shaped proteins employed by the immune system to recognize and kill harmful bacteria and viruses. The antibody identifies an antigen, which is a unique molecule of the pathogen.

Blood Plasma Derivatives Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 39.3 Billion
Market size forecast in 2028	USD 72.5 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 9.3% from 2022 to 2028
Number of Pages	232
Number of Tables	400
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Type, End User, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	A Rise in The Prevalence of Hemophilia Throughout the World  Rapidly Increasing Geriatric Population Throughout the World
Restraints	Availability of A Number of Affordable Alternatives to Blood Plasma

Regional Outlook

Region-Wise, the Blood Plasma Derivatives Market is North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America accounted for the largest revenue share of the blood plasma derivatives market. The growth of the regional market is increasing owing to an increase in the number of approvals for plasma-derived products and an increase in the number of key players manufacturing plasma-derived products in the region.

Free Valuable Insights: Global Blood Plasma Derivatives Market size to reach USD 72.5 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.

Strategies deployed in Blood Plasma Derivatives Market

• Sep-2022: Grifols entered into an agreement with the National Blood Authority of Canada, a Canadian provider of Blood Services. With this agreement, the entities aimed to accelerate the self-sufficiency of the country in terms of immunoglobulin medicines, which are necessary plasma-protein therapies in order to cure a broad range of immunodeficiencies as well as other medical malignancies.
• Jan-2022: LFB came into an agreement with Kedrion, a developer of plasma-derived medicinal products. Following this agreement, the companies aimed to expand the availability of immunoglobulin throughout France.
• Jan-2022: Kedrion formed a merger with Bio Products Laboratory, a company involved in the manufacture of human blood plasma products. Following this merger, the companies aimed to manufacture and develop a strong player within the global plasma-derivatives market. Moreover, the new merger would allow the companies to treat patients with hazardous and rare conditions with human blood plasma-derived medicines.
• Oct-2021: Kedrion Biopharma took over Prometic, a life sciences business. Through this acquisition, the company aimed to integrate the first-ever FDA-approved Congenital Plasminogen Deficiency treatment medicine of Prometic, Ryplazim. Furthermore, this acquisition would allow Kedrion to expand its footprint throughout North America.
• Mar-2021: Takeda completed its acquisition of Maverick Therapeutics, a biopharmaceutical company. Under this acquisition, Takeda would leverage the COBRA T-cell engager platform of Maverick in order to develop more efficient therapies.
• Mar-2021: Grifols acquired BPL Plasma, a subsidiary of Bio Products Laboratory. Through this acquisition, the company aimed to reinforce, expand, and diversify its robust network capacity as well as centers in order to deliver life-improving plasma-derived medicines.
• Oct-2020: Grifols took over GC Pharma, a South Korean company. Under this acquisition, Grifols aimed to possess GC Pharma's albumin purification and immunoglobulin plants throughout Montreal in order to increase its plasma supply while also accelerating its expansion across the world.
• Apr-2020: Kedrion collaborated with Kamada, a biopharmaceutical company. Under this collaboration, the companies aimed to integrate their efforts in order to develop, manufacture, and commercialize an Anti-SARS-CoV-2 polyclonal immunoglobulin product derived from human plasma as a feasible treatment in order to treat the COVID-19 infection.
• Apr-2020: LFB teamed up with Octapharma, a family-owned pharmaceutical company. Under this collaboration, the companies aimed to develop a potential therapy derived from plasma for the treatment of the COVID-19 infection and expedite a more scalable, reliable, as well as sustainable treatment of the coronavirus.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Immunodeficiency Diseases
• Hypogammaglobulinemia
• Hemophilia
• Von Willebrand's Disease
• Others

By End User

• Hospitals
• Clinics
• Others

By Type

• Immunoglobulin
• Albumin
• Factor VIII
• Factor IX
• Hyperimmune Globulin
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Biotest AG
• LFB S.A.
• CSL Limited
• Octapharma AG
• Kedrion S.p.A
• Sanofi S.A.
• Fusion Health Care Pvt. Ltd.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Blood Plasma Derivatives Market, by Application
1.4.2 Global Blood Plasma Derivatives Market, by End User
1.4.3 Global Blood Plasma Derivatives Market, by Type
1.4.4 Global Blood Plasma Derivatives Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Blood Plasma Derivatives Market

Chapter 4. Global Blood Plasma Derivatives Market by Application
4.1 Global Immunodeficiency Diseases Market by Region
4.2 Global Hypogammaglobulinemia Market by Region
4.3 Global Hemophilia Market by Region
4.4 Global Von Willebrand's Disease Market by Region
4.5 Global Others Market by Region

Chapter 5. Global Blood Plasma Derivatives Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Clinics Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Blood Plasma Derivatives Market by Type
6.1 Global Immunoglobulin Market by Region
6.2 Global Albumin Market by Region
6.3 Global Factor VIII Market by Region
6.4 Global Factor IX Market by Region
6.5 Global Hyperimmune Globulin Market by Region
6.6 Global Others Market by Region

Chapter 7. Global Blood Plasma Derivatives Market by Region
7.1 North America Blood Plasma Derivatives Market
7.1.1 North America Blood Plasma Derivatives Market by Application
7.1.1.1 North America Immunodeficiency Diseases Market by Country
7.1.1.2 North America Hypogammaglobulinemia Market by Country
7.1.1.3 North America Hemophilia Market by Country
7.1.1.4 North America Von Willebrand's Disease Market by Country
7.1.1.5 North America Others Market by Country
7.1.2 North America Blood Plasma Derivatives Market by End User
7.1.2.1 North America Hospitals Market by Country
7.1.2.2 North America Clinics Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America Blood Plasma Derivatives Market by Type
7.1.3.1 North America Immunoglobulin Market by Country
7.1.3.2 North America Albumin Market by Country
7.1.3.3 North America Factor VIII Market by Country
7.1.3.4 North America Factor IX Market by Country
7.1.3.5 North America Hyperimmune Globulin Market by Country
7.1.3.6 North America Others Market by Country
7.1.4 North America Blood Plasma Derivatives Market by Country
7.1.4.1 US Blood Plasma Derivatives Market
7.1.4.1.1 US Blood Plasma Derivatives Market by Application
7.1.4.1.2 US Blood Plasma Derivatives Market by End User
7.1.4.1.3 US Blood Plasma Derivatives Market by Type
7.1.4.2 Canada Blood Plasma Derivatives Market
7.1.4.2.1 Canada Blood Plasma Derivatives Market by Application
7.1.4.2.2 Canada Blood Plasma Derivatives Market by End User
7.1.4.2.3 Canada Blood Plasma Derivatives Market by Type
7.1.4.3 Mexico Blood Plasma Derivatives Market
7.1.4.3.1 Mexico Blood Plasma Derivatives Market by Application
7.1.4.3.2 Mexico Blood Plasma Derivatives Market by End User
7.1.4.3.3 Mexico Blood Plasma Derivatives Market by Type
7.1.4.4 Rest of North America Blood Plasma Derivatives Market
7.1.4.4.1 Rest of North America Blood Plasma Derivatives Market by Application
7.1.4.4.2 Rest of North America Blood Plasma Derivatives Market by End User
7.1.4.4.3 Rest of North America Blood Plasma Derivatives Market by Type
7.2 Europe Blood Plasma Derivatives Market
7.2.1 Europe Blood Plasma Derivatives Market by Application
7.2.1.1 Europe Immunodeficiency Diseases Market by Country
7.2.1.2 Europe Hypogammaglobulinemia Market by Country
7.2.1.3 Europe Hemophilia Market by Country
7.2.1.4 Europe Von Willebrand's Disease Market by Country
7.2.1.5 Europe Others Market by Country
7.2.2 Europe Blood Plasma Derivatives Market by End User
7.2.2.1 Europe Hospitals Market by Country
7.2.2.2 Europe Clinics Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe Blood Plasma Derivatives Market by Type
7.2.3.1 Europe Immunoglobulin Market by Country
7.2.3.2 Europe Albumin Market by Country
7.2.3.3 Europe Factor VIII Market by Country
7.2.3.4 Europe Factor IX Market by Country
7.2.3.5 Europe Hyperimmune Globulin Market by Country
7.2.3.6 Europe Others Market by Country
7.2.4 Europe Blood Plasma Derivatives Market by Country
7.2.4.1 Germany Blood Plasma Derivatives Market
7.2.4.1.1 Germany Blood Plasma Derivatives Market by Application
7.2.4.1.2 Germany Blood Plasma Derivatives Market by End User
7.2.4.1.3 Germany Blood Plasma Derivatives Market by Type
7.2.4.2 UK Blood Plasma Derivatives Market
7.2.4.2.1 UK Blood Plasma Derivatives Market by Application
7.2.4.2.2 UK Blood Plasma Derivatives Market by End User
7.2.4.2.3 UK Blood Plasma Derivatives Market by Type
7.2.4.3 France Blood Plasma Derivatives Market
7.2.4.3.1 France Blood Plasma Derivatives Market by Application
7.2.4.3.2 France Blood Plasma Derivatives Market by End User
7.2.4.3.3 France Blood Plasma Derivatives Market by Type
7.2.4.4 Russia Blood Plasma Derivatives Market
7.2.4.4.1 Russia Blood Plasma Derivatives Market by Application
7.2.4.4.2 Russia Blood Plasma Derivatives Market by End User
7.2.4.4.3 Russia Blood Plasma Derivatives Market by Type
7.2.4.5 Spain Blood Plasma Derivatives Market
7.2.4.5.1 Spain Blood Plasma Derivatives Market by Application
7.2.4.5.2 Spain Blood Plasma Derivatives Market by End User
7.2.4.5.3 Spain Blood Plasma Derivatives Market by Type
7.2.4.6 Italy Blood Plasma Derivatives Market
7.2.4.6.1 Italy Blood Plasma Derivatives Market by Application
7.2.4.6.2 Italy Blood Plasma Derivatives Market by End User
7.2.4.6.3 Italy Blood Plasma Derivatives Market by Type
7.2.4.7 Rest of Europe Blood Plasma Derivatives Market
7.2.4.7.1 Rest of Europe Blood Plasma Derivatives Market by Application
7.2.4.7.2 Rest of Europe Blood Plasma Derivatives Market by End User
7.2.4.7.3 Rest of Europe Blood Plasma Derivatives Market by Type
7.3 Asia Pacific Blood Plasma Derivatives Market
7.3.1 Asia Pacific Blood Plasma Derivatives Market by Application
7.3.1.1 Asia Pacific Immunodeficiency Diseases Market by Country
7.3.1.2 Asia Pacific Hypogammaglobulinemia Market by Country
7.3.1.3 Asia Pacific Hemophilia Market by Country
7.3.1.4 Asia Pacific Von Willebrand's Disease Market by Country
7.3.1.5 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Blood Plasma Derivatives Market by End User
7.3.2.1 Asia Pacific Hospitals Market by Country
7.3.2.2 Asia Pacific Clinics Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Blood Plasma Derivatives Market by Type
7.3.3.1 Asia Pacific Immunoglobulin Market by Country
7.3.3.2 Asia Pacific Albumin Market by Country
7.3.3.3 Asia Pacific Factor VIII Market by Country
7.3.3.4 Asia Pacific Factor IX Market by Country
7.3.3.5 Asia Pacific Hyperimmune Globulin Market by Country
7.3.3.6 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Blood Plasma Derivatives Market by Country
7.3.4.1 China Blood Plasma Derivatives Market
7.3.4.1.1 China Blood Plasma Derivatives Market by Application
7.3.4.1.2 China Blood Plasma Derivatives Market by End User
7.3.4.1.3 China Blood Plasma Derivatives Market by Type
7.3.4.2 Japan Blood Plasma Derivatives Market
7.3.4.2.1 Japan Blood Plasma Derivatives Market by Application
7.3.4.2.2 Japan Blood Plasma Derivatives Market by End User
7.3.4.2.3 Japan Blood Plasma Derivatives Market by Type
7.3.4.3 India Blood Plasma Derivatives Market
7.3.4.3.1 India Blood Plasma Derivatives Market by Application
7.3.4.3.2 India Blood Plasma Derivatives Market by End User
7.3.4.3.3 India Blood Plasma Derivatives Market by Type
7.3.4.4 South Korea Blood Plasma Derivatives Market
7.3.4.4.1 South Korea Blood Plasma Derivatives Market by Application
7.3.4.4.2 South Korea Blood Plasma Derivatives Market by End User
7.3.4.4.3 South Korea Blood Plasma Derivatives Market by Type
7.3.4.5 Singapore Blood Plasma Derivatives Market
7.3.4.5.1 Singapore Blood Plasma Derivatives Market by Application
7.3.4.5.2 Singapore Blood Plasma Derivatives Market by End User
7.3.4.5.3 Singapore Blood Plasma Derivatives Market by Type
7.3.4.6 Malaysia Blood Plasma Derivatives Market
7.3.4.6.1 Malaysia Blood Plasma Derivatives Market by Application
7.3.4.6.2 Malaysia Blood Plasma Derivatives Market by End User
7.3.4.6.3 Malaysia Blood Plasma Derivatives Market by Type
7.3.4.7 Rest of Asia Pacific Blood Plasma Derivatives Market
7.3.4.7.1 Rest of Asia Pacific Blood Plasma Derivatives Market by Application
7.3.4.7.2 Rest of Asia Pacific Blood Plasma Derivatives Market by End User
7.3.4.7.3 Rest of Asia Pacific Blood Plasma Derivatives Market by Type
7.4 LAMEA Blood Plasma Derivatives Market
7.4.1 LAMEA Blood Plasma Derivatives Market by Application
7.4.1.1 LAMEA Immunodeficiency Diseases Market by Country
7.4.1.2 LAMEA Hypogammaglobulinemia Market by Country
7.4.1.3 LAMEA Hemophilia Market by Country
7.4.1.4 LAMEA Von Willebrand's Disease Market by Country
7.4.1.5 LAMEA Others Market by Country
7.4.2 LAMEA Blood Plasma Derivatives Market by End User
7.4.2.1 LAMEA Hospitals Market by Country
7.4.2.2 LAMEA Clinics Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA Blood Plasma Derivatives Market by Type
7.4.3.1 LAMEA Immunoglobulin Market by Country
7.4.3.2 LAMEA Albumin Market by Country
7.4.3.3 LAMEA Factor VIII Market by Country
7.4.3.4 LAMEA Factor IX Market by Country
7.4.3.5 LAMEA Hyperimmune Globulin Market by Country
7.4.3.6 LAMEA Others Market by Country
7.4.4 LAMEA Blood Plasma Derivatives Market by Country
7.4.4.1 Brazil Blood Plasma Derivatives Market
7.4.4.1.1 Brazil Blood Plasma Derivatives Market by Application
7.4.4.1.2 Brazil Blood Plasma Derivatives Market by End User
7.4.4.1.3 Brazil Blood Plasma Derivatives Market by Type
7.4.4.2 Argentina Blood Plasma Derivatives Market
7.4.4.2.1 Argentina Blood Plasma Derivatives Market by Application
7.4.4.2.2 Argentina Blood Plasma Derivatives Market by End User
7.4.4.2.3 Argentina Blood Plasma Derivatives Market by Type
7.4.4.3 UAE Blood Plasma Derivatives Market
7.4.4.3.1 UAE Blood Plasma Derivatives Market by Application
7.4.4.3.2 UAE Blood Plasma Derivatives Market by End User
7.4.4.3.3 UAE Blood Plasma Derivatives Market by Type
7.4.4.4 Saudi Arabia Blood Plasma Derivatives Market
7.4.4.4.1 Saudi Arabia Blood Plasma Derivatives Market by Application
7.4.4.4.2 Saudi Arabia Blood Plasma Derivatives Market by End User
7.4.4.4.3 Saudi Arabia Blood Plasma Derivatives Market by Type
7.4.4.5 South Africa Blood Plasma Derivatives Market
7.4.4.5.1 South Africa Blood Plasma Derivatives Market by Application
7.4.4.5.2 South Africa Blood Plasma Derivatives Market by End User
7.4.4.5.3 South Africa Blood Plasma Derivatives Market by Type
7.4.4.6 Nigeria Blood Plasma Derivatives Market
7.4.4.6.1 Nigeria Blood Plasma Derivatives Market by Application
7.4.4.6.2 Nigeria Blood Plasma Derivatives Market by End User
7.4.4.6.3 Nigeria Blood Plasma Derivatives Market by Type
7.4.4.7 Rest of LAMEA Blood Plasma Derivatives Market
7.4.4.7.1 Rest of LAMEA Blood Plasma Derivatives Market by Application
7.4.4.7.2 Rest of LAMEA Blood Plasma Derivatives Market by End User
7.4.4.7.3 Rest of LAMEA Blood Plasma Derivatives Market by Type

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Grifols, S.A
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Biotest AG (Tiancheng International Investment Limited)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 LFB S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 CSL Limited (CSL Behring)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Octapharma AG
8.7.1 Company Overview
8.8 Kedrion S.p.A
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fusion Health Care Pvt. Ltd.
8.10.1 Company Overview

TABLE 1 Global Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 2 Global Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 3 Global Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 4 Global Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 5 Global Immunodeficiency Diseases Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Immunodeficiency Diseases Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Hypogammaglobulinemia Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Hypogammaglobulinemia Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Hemophilia Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Hemophilia Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Von Willebrand's Disease Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Von Willebrand's Disease Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 16 Global Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 17 Global Hospitals Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Hospitals Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Clinics Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Clinics Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 24 Global Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 25 Global Immunoglobulin Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Immunoglobulin Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Albumin Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Albumin Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Factor VIII Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Factor VIII Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Factor IX Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Factor IX Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Hyperimmune Globulin Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Hyperimmune Globulin Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Blood Plasma Derivatives Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Blood Plasma Derivatives Market by Region, 2022 - 2028, USD Million
TABLE 39 North America Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 40 North America Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 41 North America Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 42 North America Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 43 North America Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 54 North America Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 55 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Clinics Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Clinics Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 62 North America Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 63 North America Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Albumin Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Albumin Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 73 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 77 US Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 78 US Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 79 US Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 80 US Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 81 US Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 82 US Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 83 US Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 84 US Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 85 Canada Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 86 Canada Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 87 Canada Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 88 Canada Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 89 Canada Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 90 Canada Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 91 Canada Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 92 Canada Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 93 Mexico Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 94 Mexico Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 95 Mexico Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 96 Mexico Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 97 Mexico Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 98 Mexico Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 99 Mexico Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 100 Mexico Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 101 Rest of North America Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 102 Rest of North America Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 103 Rest of North America Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 104 Rest of North America Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 105 Rest of North America Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 106 Rest of North America Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 107 Rest of North America Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 108 Rest of North America Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 109 Europe Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 110 Europe Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 111 Europe Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 112 Europe Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 113 Europe Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 124 Europe Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 125 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 126 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 127 Europe Clinics Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Clinics Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 132 Europe Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 133 Europe Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Albumin Market by Country, 2018 - 2021, USD Million
TABLE 136 Europe Albumin Market by Country, 2022 - 2028, USD Million
TABLE 137 Europe Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 141 Europe Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 142 Europe Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 143 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 144 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 145 Europe Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 147 Germany Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 148 Germany Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 149 Germany Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 150 Germany Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 151 Germany Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 152 Germany Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 153 Germany Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 154 Germany Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 155 UK Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 156 UK Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 157 UK Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 158 UK Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 159 UK Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 160 UK Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 161 UK Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 162 UK Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 163 France Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 164 France Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 165 France Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 166 France Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 167 France Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 168 France Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 169 France Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 170 France Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 171 Russia Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 172 Russia Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 173 Russia Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 174 Russia Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 175 Russia Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 176 Russia Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 177 Russia Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 178 Russia Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 179 Spain Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 180 Spain Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 181 Spain Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 182 Spain Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 183 Spain Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 184 Spain Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 185 Spain Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 186 Spain Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 187 Italy Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 188 Italy Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 189 Italy Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 190 Italy Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 191 Italy Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 192 Italy Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 193 Italy Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 194 Italy Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 195 Rest of Europe Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 196 Rest of Europe Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 197 Rest of Europe Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 198 Rest of Europe Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 199 Rest of Europe Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 200 Rest of Europe Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 201 Rest of Europe Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 202 Rest of Europe Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 209 Asia Pacific Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 210 Asia Pacific Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 211 Asia Pacific Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 215 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 216 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 217 Asia Pacific Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 218 Asia Pacific Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 219 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 220 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 221 Asia Pacific Clinics Market by Country, 2018 - 2021, USD Million
TABLE 222 Asia Pacific Clinics Market by Country, 2022 - 2028, USD Million
TABLE 223 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 224 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 225 Asia Pacific Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 226 Asia Pacific Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 227 Asia Pacific Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 228 Asia Pacific Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 229 Asia Pacific Albumin Market by Country, 2018 - 2021, USD Million
TABLE 230 Asia Pacific Albumin Market by Country, 2022 - 2028, USD Million
TABLE 231 Asia Pacific Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 232 Asia Pacific Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 233 Asia Pacific Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 234 Asia Pacific Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 235 Asia Pacific Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 236 Asia Pacific Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 237 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 238 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 239 Asia Pacific Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 240 Asia Pacific Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 241 China Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 242 China Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 243 China Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 244 China Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 245 China Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 246 China Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 247 China Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 248 China Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 249 Japan Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 250 Japan Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 251 Japan Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 252 Japan Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 253 Japan Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 254 Japan Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 255 Japan Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 256 Japan Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 257 India Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 258 India Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 259 India Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 260 India Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 261 India Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 262 India Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 263 India Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 264 India Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 265 South Korea Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 266 South Korea Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 267 South Korea Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 268 South Korea Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 269 South Korea Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 270 South Korea Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 271 South Korea Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 272 South Korea Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 273 Singapore Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 274 Singapore Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 275 Singapore Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 276 Singapore Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 277 Singapore Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 278 Singapore Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 279 Singapore Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 280 Singapore Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 281 Malaysia Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 282 Malaysia Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 283 Malaysia Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 284 Malaysia Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 285 Malaysia Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 286 Malaysia Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 287 Malaysia Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 288 Malaysia Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 289 Rest of Asia Pacific Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 290 Rest of Asia Pacific Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 291 Rest of Asia Pacific Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 292 Rest of Asia Pacific Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 293 Rest of Asia Pacific Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 294 Rest of Asia Pacific Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 295 Rest of Asia Pacific Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 296 Rest of Asia Pacific Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 297 LAMEA Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 298 LAMEA Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 299 LAMEA Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 300 LAMEA Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 301 LAMEA Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 302 LAMEA Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 303 LAMEA Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 304 LAMEA Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 305 LAMEA Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 306 LAMEA Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 307 LAMEA Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 308 LAMEA Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 309 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 310 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 311 LAMEA Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 312 LAMEA Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 313 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 314 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 315 LAMEA Clinics Market by Country, 2018 - 2021, USD Million
TABLE 316 LAMEA Clinics Market by Country, 2022 - 2028, USD Million
TABLE 317 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 318 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 319 LAMEA Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 320 LAMEA Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 321 LAMEA Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 322 LAMEA Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 323 LAMEA Albumin Market by Country, 2018 - 2021, USD Million
TABLE 324 LAMEA Albumin Market by Country, 2022 - 2028, USD Million
TABLE 325 LAMEA Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 326 LAMEA Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 327 LAMEA Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 328 LAMEA Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 329 LAMEA Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 330 LAMEA Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 331 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 332 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 333 LAMEA Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 334 LAMEA Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 335 Brazil Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 336 Brazil Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 337 Brazil Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 338 Brazil Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 339 Brazil Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 340 Brazil Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 341 Brazil Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 342 Brazil Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 343 Argentina Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 344 Argentina Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 345 Argentina Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 346 Argentina Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 347 Argentina Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 348 Argentina Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 349 Argentina Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 350 Argentina Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 351 UAE Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 352 UAE Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 353 UAE Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 354 UAE Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 355 UAE Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 356 UAE Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 357 UAE Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 358 UAE Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 359 Saudi Arabia Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 360 Saudi Arabia Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 361 Saudi Arabia Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 362 Saudi Arabia Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 363 Saudi Arabia Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 364 Saudi Arabia Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 365 Saudi Arabia Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 366 Saudi Arabia Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 367 South Africa Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 368 South Africa Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 369 South Africa Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 370 South Africa Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 371 South Africa Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 372 South Africa Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 373 South Africa Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 374 South Africa Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 375 Nigeria Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 376 Nigeria Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 377 Nigeria Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 378 Nigeria Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 379 Nigeria Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 380 Nigeria Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 381 Nigeria Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 382 Nigeria Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 383 Rest of LAMEA Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 384 Rest of LAMEA Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 385 Rest of LAMEA Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 386 Rest of LAMEA Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 387 Rest of LAMEA Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 388 Rest of LAMEA Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 389 Rest of LAMEA Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 390 Rest of LAMEA Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 391 Key Information – Bayer AG
TABLE 392 Key Information – Takeda Pharmaceutical Company Limited
TABLE 393 Key information – Grifols, S.A.
TABLE 394 key information – Biotest AG
TABLE 395 Key Information – LFB S.A
TABLE 396 key Information – CSL Limited
TABLE 397 Key Information – Octapharma AG
TABLE 398 key Information – Kedrion S.p.A
TABLE 399 Key Information – Sanofi S.A.
TABLE 400 Key Information – Fusion Health Care Pvt. Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Blood Plasma Derivatives Market share by Application, 2021
FIG 3 Global Blood Plasma Derivatives Market share by Application, 2028
FIG 4 Global Blood Plasma Derivatives Market by Application, 2018 - 2028, USD Million
FIG 5 Global Blood Plasma Derivatives Market share by End User, 2021
FIG 6 Global Blood Plasma Derivatives Market share by End User, 2028
FIG 7 Global Blood Plasma Derivatives Market by End User, 2018 - 2028, USD Million
FIG 8 Global Blood Plasma Derivatives Market share by Type, 2021
FIG 9 Global Blood Plasma Derivatives Market share by Type, 2028
FIG 10 Global Blood Plasma Derivatives Market by Type, 2018 - 2028, USD Million
FIG 11 Global Blood Plasma Derivatives Market share by Region, 2021
FIG 12 Global Blood Plasma Derivatives Market share by Region, 2028
FIG 13 Global Blood Plasma Derivatives Market by Region, 2018 - 2028, USD Million
FIG 14 Recent strategies and developments: Grifols, S.A.
FIG 15 Recent strategies and developments: Kedrion S.p.A